Synergistic anti-Newcastle disease virus activity of pokeweed antiviral protein, ribavirin, and guanidine

Canadian Journal of Microbiology

Volumn 44, Issue 7, 1998, Pages 702-705

  Weaver, Eric ^a   Aron, Gary M ^a  

^a Texas State University   (United States)

Author keywords

Guanidine; Newcastle disease virus; Pokeweed antiviral protein; Ribavirin; Synergy

Indexed keywords

GUANIDINE DERIVATIVE; POKEWEED ANTIVIRUS PROTEIN; RIBAVIRIN;

DISEASE CONTROL; SYNERGISM; VIRAL DISEASE;

ANTIVIRAL ACTIVITY; ARTICLE; BIRD DISEASE; DISEASE ACTIVITY; ENZYME ACTIVITY; GENE TARGETING; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; RNA TRANSLATION; VIRUS ACTIVATION; VIRUS INHIBITION; VIRUS REPLICATION;

AVES; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; PHYTOLACCACEAE; POSIBACTERIA;

EID: 85047679057     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w98-053     Document Type: Article

References (12)

1. Aron, G.M., and Irvin, J.D. 1980. Inhibition of herpes simplex virus multiplication by the pokeweed antiviral protein. Antimicrob. Agents Chemother. 17: 1032-1033.
2. Aron, G.M., and Irvin, J.D. 1988. Cytotoxicity of pokeweed antiviral protein. Cytobios, 55: 105-111.
3. Irvin, J.D. 1983. Pokeweed antiviral protein. Pharmacol. Ther. 21: 371-387.
4. Irvin, J.D. 1995. Antiviral proteins from Phytolacca. In Antiviral proteins in higher plants. Edited by M. Chessin, D. DeBorde, and A. Zipf. CRC Press, Boca Raton, Fla. pp. 65-93.
5. Lee, T., Crowell, M., Shearer, M.H., Aron, G.M., and Irvin, J.D. 1990. Poliovirus-mediated entry of pokeweed antiviral protein. Antimicrob. Agents Chemother. 34: 2034-2037.
6. Nikolaeva, L., and Galabov, A.S. 1995. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication. Acta Virol. (Engl. Ed.), 39(5-6): 235-241.
7. Pauwels, R., and Declercq, E. 1996. Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. J. Acquired Immune Defic. Syndr. 11(3): 211-221.
8. Prichard, M.N., Prichard, L.E., and Shipman, C. 1993. Strategic design and three dimensional analysis of antiviral drug combinations. Antimicrob. Agents Chemother. 37: 540-545.
9. Shannon, W.M. 1984. Mechanism of action and pharmacology: chemical agents. 2nd ed. In Antiviral agents and viral diseases of man. Edited by G.J. Gallasso, T.C. Merigan, and R.A. Buchanan. Raven Press, New York. pp. 55-121.
10. Shigeta, S., Mori, S., Watanabe, J., Soeda, S., Takahashi, K., and Yamase, T. 1997. Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo. Antimicrob. Agents Chemother. 41: 1423-1427.
11. Tershak, D.R., Yin, F.H., and Korant, B.D. 1982. Guanidine. In Chemotherapy of viral infections. Edited by P.E. Came and L.A. Caliguiri. Springer-Verlag, Berlin, pp. 343-375.
12. Zarling, J.M., Moran, P.A., Haffar, O., Sias, J., Richman, D.D., Spina, C.A., Myers, D.E., Kuelbebeck, V., Ledbetter, J.A., and Uckun, F.M. 1990. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature (London), 347: 92-95.